Metraipolis › archive › dc_75ca8f5d949e

Cannabis Medicine 2.0: Nanotechnology-Based Delivery Systems for Synthetic and Chemically Modified Cannabinoids for Enhanced Therapeutic Performance — Europe PMC PMID:40863840

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40863840
DOI
10.3390/nano15161260
License (as archived)
solo-consultazione
Archived
2026-11-10T14:23:49.158Z
SHA-256 of the archived text
282e9a4e3610f1fa9b124c79f9b412367746e3c9a913f9ec3005257cc06f1ef3
Stable URL of this page
https://metraipolis.com/documento/dc_75ca8f5d949e

How to cite

Cannabis Medicine 2.0: Nanotechnology-Based Delivery Systems for Synthetic and Chemically Modified Cannabinoids for Enhanced Therapeutic Performance — Europe PMC PMID:40863840 — Europe PMC (en), https://europepmc.org/article/MED/40863840 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_75ca8f5d949e (Metraipolis archive dc_75ca8f5d949e, sha256 282e9a4e3610f1fa9b124c79f9b412367746e3c9a913f9ec3005257cc06f1ef3)
BibTeX
@misc{dc75ca8f5d949e,
  title = {Cannabis Medicine 2.0: Nanotechnology-Based Delivery Systems for Synthetic and Chemically Modified Cannabinoids for Enhanced Therapeutic Performance — Europe PMC PMID:40863840},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40863840},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_75ca8f5d949e; sha256 282e9a4e3610f1fa9b124c79f9b412367746e3c9a913f9ec3005257cc06f1ef3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40863840. Agents can read the archived copy with the MCP tool read_document.